STAT

The Senate could soon pass an opioids package. But a new law is still a long way away

The House passed a big opioids bill, the Senate is about to vote on its own version — but a law? That’s a long way off.
A man walks by a billboard for a drug recovery center in Youngstown, Ohio.

WASHINGTON — The Senate is likely to pass a comprehensive bill to address the opioid crisis in the coming weeks. The House did so in June.

But the finish line on that long-discussed priority remains a long way off.

Lawmakers have left untouched many of the bill’s most contentious issues, like debates over patient privacy and expensive changes to Medicaid payments for addiction treatment. There’s no sign yet they’ll iron out those issues before the Senate votes.

That procrastination means a select group of lawmakers will spend September and October — if not longer — hammering out the contentious details. A final vote, lawmakers, congressional aides, and

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks